Microbial production of chemicals driven by CRISPR-Cas systems by Shi, Shuobo et al.
Microbial production of chemicals driven by CRISPR-Cas systems
Downloaded from: https://research.chalmers.se, 2021-08-31 11:16 UTC
Citation for the original published paper (version of record):
Shi, S., Qi, N., Nielsen, J. (2022)
Microbial production of chemicals driven by CRISPR-Cas systems
Current Opinion in Biotechnology, 73: 34-42
http://dx.doi.org/10.1016/j.copbio.2021.07.002
N.B. When citing this work, cite the original published paper.
research.chalmers.se offers the possibility of retrieving research publications produced at Chalmers University of Technology.
It covers all kind of research output: articles, dissertations, conference papers, reports etc. since 2004.
research.chalmers.se is administrated and maintained by Chalmers Library
(article starts on next page)
Microbial production of chemicals driven
by CRISPR-Cas systems
Shuobo Shi1, Nailing Qi1 and Jens Nielsen1,2,3
Available online at www.sciencedirect.com
ScienceDirectMicroorganisms have provided an attractive route for
biosynthesis of various chemicals from renewable resources.
CRISPR-Cas systems have served as powerful mechanisms
for generating cell factories with desirable properties by
manipulating nucleic acids quickly and efficiently. The CRISPR-
Cas system provides a toolbox with excellent opportunities for
identifying better biocatalysts, multiplexed fine-tuning of
metabolic flux, efficient utilization of low-cost substrates, and
improvement of metabolic robustness. The overall goal of this
review highlights recent advances in the development of
microbial cell factories for chemical production using various
CRISPR-Cas systems. The perspectives for further
development or applications of CRISPR-Cas systems for strain
improvement are also discussed.
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Introduction
Microbial fermentation has been successfully introduced
for the commercial production of many chemicals [1,2],
such as citric acid and 1,3-propanediol. This strategy has
drawn increasing attention because of its feasibility, con-
venient manipulation, outstanding cost performance and
fewer greenhouse gas emissions. In this context the
Design–Build–Test–Learn (DBTL) cycle is indispens-
able for the construction of an advanced cell factory [2,3],
which always needs several rounds of engineering due to
the complexity of cellular metabolism. Traditionally
‘Build’ has been seen as a rate-limiting step in the DBTL
cycle, as it is generally time consuming and expensive toCurrent Opinion in Biotechnology 2022, 73:34–42 build engineered strains. Advances in strain engineering
technologies in the last decade has, however, reduced
time and costs associated with the construction of effi-
cient cell factories.
Clustered regularly interspaced short palindromic repeats
(CRISPR) and CRISPR-associated (Cas) systems are
progressing rapidly and have become the gold standard
technology for genetic and metabolic engineering [4],
thanks to easy-to-design, high specificity, and high func-
tional genome-editing efficiency. Now CRISPR-based
toolbox has been demonstrated to implement most of
the genetic manipulations in high efficiency, and is there-
fore providing a remarkable solution for construction
desirable cell factories (Figure 1).
CRISPR-Cas systems originate as a heritable adaptive
immunity reaction of bacteria and archaea, by introducing
a double-strand break (DSB) at a specific target site
complementary to crRNA or single-guide RNA (gRNA).
As shown in Figure 2, the DSB will enable genetic
insertions, deletions, or replacement through intrinsic
DNA repair processes; what is more, dCas (nuclease-
deficient Cas protein) can serve as a sequence recognizer
without introducing a DSB, and flexible transcriptional
regulation can be achieved by recruiting effector domains
to the nuclease-deficient CRISPR complex [5]. More
advanced functions for targeted modifications have been
empowered by other functional effectors, such as meth-
ylation by fusion to methyltransferase [6] and base editing
by fusion to deaminases [7]. The establishment of a
CRISPR-Cas system with orthogonal functions has
emerged as a powerful and versatile tool to implement
the combinatorial and multiplex modifications required
for constructing a superior cell factory [8–10].
The advanced CRISPR-Cas system has been shown to
revolutionize strain construction faster and more reliably
in many ways (Table 1), such as pathway construction and
optimization, enzyme engineering and evolution, extend-
ing the substrate scope, and metabolic robustness
improvement. This review focuses on the recent
advances and immediate challenges for creating efficient
cell factories for chemical production driven by CRISPR-
Cas systems.
Assembly of biosynthetic pathways for target
chemical production
There are many chemicals that can be produced via
microbes [11]. However, some chemicals are non-naturalwww.sciencedirect.com
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CRISPR based perturbations
CRISPR-based perturbations for the development of advanced
microbial cell factories for production of various chemicals.
The construction of a superior cell factory is the key for industrial
biotechnology process, which required combinatorial and multiplex
modifications in cell metabolisms, such as insertion, deletion,
disruption, point mutation, activation, repression. CRISPR-Cas system
has been demonstrated to implement most of the genetic
manipulations from the enzyme to genome level, which was
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Scheme of the CRISPR-Cas systems for genome editing and
regulation.
(a) Basic applications of the CRISPR-Cas system for DSB-based
genome editing, including gene deletion, mutation or disruption,
insertion. In this system, a Cas nuclease (i.e. Cas9) binds to a specific
site in the genome guided by gRNA, and generates a DSB. Then
desired genome editing could be achieved by HR or NHEJ. Donors
are required when precise editing is conducted by HR. (b) Advanced
applications of the CRISPR-dCas system for non-DSB-based genome
editing and regulation, including base editing, transcriptional activation
(CRISPRa) and repression (CRISPRi). In this system, a dCas (dead
Cas or nuclease-deficient Cas) is obtained by mutating a Cas
nuclease, which can still recognize the binding sites but without the
formation of DSB. Then, a customized function can be achieved by
recruiting a desired effector (e.g. deaminase). DSB, double-strand
break; HR, homology repair; NHEJ, non-homologous end joining.to the host, and heterologous pathways must be estab-
lished in the first step. The majority of previous endea-
vors employed non-integrative plasmids, but suffered
from inherent problems of clonal variations, instability,
and selection pressure requirements. In view of these
limitations, as indicated in Figure 3a, the CRISPR-Cas
system greatly facilitates the assembly, or knock-in, of
heterologous pathways in chromosomes for stable expres-
sion of pathway genes [12,13]. It has been shown that the
integration of large synthetic pathways into chromosomes
of Escherichia coli for the production of 5-methylpyrazine-
2-carboxylic acid (MPCA), and the integrated copywww.sciencedirect.com number of xylM and xylA could be adjusted by selecting
different integration sites, improving the production of
MPCA to 15.6 g/L [13].
Recently, six desirable intergenic loci were screened and
engineering to build multiplex integration platform [14].
Based on these pre-characterized sites, a simultaneous
integration of 2-genes, 3-genes, 4-genes, 5-genes, or 6-
genes was achieved to produce betalain or kauniolide. In
parallel, successful examples for pathway integration
could also be found in non-conventional microbes, suchCurrent Opinion in Biotechnology 2022, 73:34–42
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Table 1
Selected CRISPR-Cas mediated metabolic engineering works for microbial chemical production
Host Types of
modifications
Products or desired traits Achievements Reference





Improving the MPCA titer to 15.6 g/L [13]
S. cerevisiae Pathway
integration
Betalain or kauniolide A simultaneous integration of biosynthetic pathways





Itaconic acid Improving the itaconic acid production to 401 mg/L [15]
Z. mobilis Pathway
integration
Lactate Improving the lactate production to 2.21 g/L [16]
S. cerevisiae Pathway
integration
2, 3-Butanediol A up to 25 copies of pathway integration, and improved
2, 3-butanediol production to 1.7 g/L
[18]
Optimization of production pathways for target chemicals
S. cerevisiae Deletion Free fatty acids (FFA) Giving a 30-fold increase of FFA production [19]
E. coli Repression Isopentenol Up to 98% enhancement in production of isopentenol [20]
Synechocystis sp.
PCC 6803
Repression Fatty alcohols Up to 3-fold enhancement in production of
octadecanol and gave the highest specific titers
(10.3 mg/g CDW)
[21]
M. xanthus Activation Epothilones Improving the epothilones production to >20 mg/L [23]
K. marxianus Combinatorial
integration
2-Phenylethanol Improving the 2-phenylethanol production to 1943 mg/
L
[24]
S. cerevisiae Activation and
repression
3-Hydroxypropionic acid (3-HP) Giving a 36% increase of 3-HP production [25]
S. cerevisiae Activation and
repression
Carotenoid and triacylglycerols (TAGs) A modest increase in the carotenoid-associated

















Base editing Lycopene Achieving a lycopene yield of 2.9 mg/gCDW [7]
B. subtilis Activation and
repression
N-Acetylglucosamine Achieving a N-acetylglucosamine production at
131.6 g/L
[28]
Yarrowia lipolytica Repression Naringenin Giving a 74.8% increase of naringenin production [29]
Screening or engineering of alternative enzymes
S. cerevisiae Integration Carotenoids An 11-fold improvement in carotenoid production by
directed evolution of two essential enzymes
[30]
E. coli Integration Tryptophan (Trp) Identification of variants of AroG with increased
resistance to feedback inhibition and improved the Trp
production by 38.5%
[31]
E. coli Site targeted
mutagenesis
Novel variant of rpsE Identification of novel mutations in rpsE that conferred
spectinomycin resistance
[32]




Proline Identification of a variant of ornithine aminotransferase
that contributed a proline production of 38.4 g/L
[33]
Diversifying the substrate scope
E. coli Integration Ability for xylose-utilization A 3-fold increase of the xylose-utilization rate [34]
S. cerevisiae Integration Ability for xylose-utilization Achievement of simultaneous co-fermentation of






Base editing Ability for utilization of glycerol and
xylose
Improved glycerol utilization capability in B. subtilis
and improved xylose utilization capability in C.
glutamicum,
[7]
E. coli Integration, and
deletion
Ability for simultaneous utilization of
acetate and glucose
Improving the carbon molar yield from 0.67 to
0.75 mol/mol for glycolate production
[37]
E. coli Deletion Ability for utilization of ethanol Production of 1.1 g/L polyhydroxybutyrate or 24 mg/L
prenol from ethanol
[38]
Current Opinion in Biotechnology 2022, 73:34–42 www.sciencedirect.com
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Table 1 (Continued )
Host Types of
modifications
Products or desired traits Achievements Reference
Improvement of metabolic robustness
S. cerevisiae Integration Resistance to ethanol Improving ethanol tolerance and giving an 2-fold
improvement for ethanol production
[40]
E. coli Integration Resistance to styrene Improving styrene tolerance and giving an 3.45-fold




Repression Resistance to lactate Identification of a single repression of bcp2 for a 49%
improvement of growth rate in cultures with added L-
lactate
[42]
S. cerevisiae Integration, and
deletion
Resistance to various environmental
perturbations, including higher
temperature
Identification of 68 small open reading frames which
are vital for cell’s robustness
[43]
S. cerevisiae Activation Thermotolerance Achieving a faster growth rate in OLE1-overexpressing
strain than the control strains at 42C
[44]






Resistance to furfural In the presence of 17.5 mM furfural, the screened strain
can consume most of glucose in 2 days, while the
control strain failed to grow after 6 days
[8]
S. cerevisiae Activation and
repression
Resistance to wheat straw hydrolysate Giving a 2.3-fold increase in final biomass yield in
medium with wheat straw hydrolysate
[46]as the implementation of itaconic acid production in
Pichia kudriavzevii [15] and lactate production in Zymo-
monas mobilis [16]. To further increase the copy number
for a higher expression, DSB were generated at delta sites
by the CRISPR-Cas system, and an up to 25-copy inte-
gration could be achieved in one step, resulting in engi-
neered strains for efficient production of 2,3-butanediol
[17,18].
Optimization of metabolic flux for target
chemical production
On theother hand, cells have been notevolved for chemical
production. Thus, optimization of metabolic flux is
required for maximizing the production, such as deletion,
knock-down or overexpression of target genes, which has
been enabled with the assistance of CRISPR technology in
a markerless and efficient manner (Figure 3b). For exam-
ple, to achieve high production of free fatty acids (FFAs),
CRISPR-Cas was used to simplify the lipid network of
yeast by deleting eight non-essential FA utilization genes
in ten days, giving a 30-fold increase in FFA production
[19]. Similarly, the competing pathway could also be
knocked down by CRISPR interference (CRISPRi), where
the inactive Cas enzyme (dCas) was used. CRISPRi was
demonstrated to improve the production of isopentenol in
E. coli [20] or fatty alcohols in Synechocystis [21] at varying
strengths of repression for combinations of several target
genes.
Overexpressing genes of interest is another widespread
genetic manipulation, and CRISPR-Cas has been repur-
posed to activate gene expression (CRISPRa) when a
transcriptional activator was coupled to dCas. Initially,
CRISPRa was actively employed in eukaryotes since
there are many activation domains reported [10]. Now,www.sciencedirect.com a generalizable platform was available to screen and select
transcriptional activators that can be used in different
bacterial species [22]. Recently, CRISPRa was shown to
upregulate the expression of biosynthetic genes for the
production of epothilones in Myxococcus xanthus [23]. In
this study, the activation effects of each gene in the
pathway were also clarified by using different sgRNAs
and activator proteins. Generally, CRISPRi or CRISPRa
is more suitable for multiplex engineering, as multiplex
deletion/integration would be more harmful to the host.
Because of the complex regulatory metabolic network of
living cells, combinatorial and multiplex pathway editing
is needed to alter cell metabolism. For example, a multi-
gene integration system mediated by CRISPR-Cas9 was
developed for pathway refactoring in Kluyveromyces marx-
ianus [24]. The system was demonstrated to create a 33
combinatorial library to optimize the expression of three
key shikimate pathway genes, ARO4, ARO7 and
PHA2. Later, simultaneous transcriptional activation or
repression was reported for different strategies that
improved the production of target chemicals. Recently,
a platform tool was established to upregulate or down-
regulate gene expression using dCas9 coupled to the
VP64-p65-Rta (VPR) [25]. This tool was used to allow
transcriptional perturbation of the 168 selected genes,
and increased the production yield of 3-hydroxypropionic
acid by 36% through targeting the gene encoding ade-
nylate kinase 1. Another work has also shown the use of
RNA scaffold systems for repression or activation of target
gene expression to enhance the production of carotenoid
and triacylglycerols [26].
In a recent study, three orthogonal Cas proteins were used
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Applications of CRISPR-Cas toolbox in development of microbial cell factories for chemical production.
(a) Assembly of biosynthetic pathways for target chemical production. Several biosynthetic enzymes are assembled into functional metabolic
structures, and the integrated copy number could be adjusted at the same time by selecting desirable intergenic loci. (b) Optimization of
metabolic flux for target chemical production. Combinatorial and multiplexed genetic manipulation is established to optimize or balance metabolic
flux to target chemicals. (c) Identification of alternative enzymes for biocatalyst. Enzymes with altered or enhanced activities could be created by
direct integration of protein variants or continuously targeted in vivo mutagenesis. Protein variants could be generated by error-prone PCR, or
(semi-) rational design. The in vivo mutagenesis could be achieved by using engineered DNA polymerases (nCas-Pol) targeted to loci via CRISPR-
guided nickases. (d) Diversification of the substrate scope. Considerable efforts have been expended to efficiently use renewable substrates or
alternative substrates with a higher theoretical yield. (e) Improvement of metabolic robustness. Metabolic robustness or tolerance have been
improved to various cell stressors via screening of functional genes.transcriptional activation, interference, and gene dele-
tion, which was applied to enhance the production of
b-carotene by threefold in a single step in Saccharomyces
cerevisiae [10]. Later, it also demonstrated that a single
Cas9-VPR protein can accomplish these tri-combinatorial
manipulations and improve a-santalene production 2.66-
fold [27]. Following this, a CRISPR-guided base editor
was designed for combinatorial optimization of ten
endogenous genes for lycopene biosynthesis by diversi-
fying tailored ribosome binding sites (RBSs) [7]. In this
method (named BETTER), the library was generated in
situ, and the theoretical maximum library can be up to
2.7  1033, providing a significant advantage for diversi-
fying multigene expression.
Dynamic control of metabolic flux is highly effective in
optimizing biological systems. Recently, the production
of N-acetylglucosamine was increased to 131.6 g/L by
Bacillus subtilis using CRISPRi-based NOT gates with the
biosensor of intermediate glucosamine-6-phosphate [28];
similarly, the production of naringenin was increased by
74.8%, enabled by the combined use of CRISPRi and a
fatty acid sensor [29]. Both dynamically self-adjust the
expression of the pathway genes using an autoregulatory
genetic circuit for a balanced flux to the biosynthesis ofCurrent Opinion in Biotechnology 2022, 73:34–42 the target product, which can be used as a generalized tool
for pathway optimization. However, these proposed pro-
grammable circuits are limited to the availability of
biosensors.
Screening or engineering of alternative
enzymes for biocatalyst
Enzymes are the basic units for the design and construc-
tion of efficient chemical-producing pathways. However,
natural enzymes may have limitations, such as lower
catalytic efficiency or feedback inhibition. Recently, as
shown in Figure 3c, the CRISPR-Cas system was shown
to directly and effectively integrate protein variants of
interest into the yeast genome with efficiencies reaching
98–99% [30]. Using this method, two key enzyme variants
in the mevalonate pathway were identified with improved
activity from millions of mutants by colony color, which
resulted in an 11-fold improvement in carotenoid produc-
tion. Similarly, when the integrated library was coupled
with growth, several Phe-resistant AroG variants were
found that can be used to facilitate the biosynthesis of
aromatic amino acids [31].
In parallel, the mutation library of a target enzyme was
also demonstrated as being capable of generation in vivowww.sciencedirect.com
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of user-defined genes (Figure 3c), called EvolvR [32]. In
EvolvR, nucleotides within user-defined regions were
targeted for mutagenesis using CRISPR-guided engi-
neered DNA polymerases, offering a mutation rate 7
770 000-fold greater than wild-type, and novel mutations
of rpsE gene were identified that conferred spectinomy-
cin resistance. Later, EvolvR was used to identify a
variant of ornithine aminotransferase that showed 2.85-
fold improvement in catalytic efficiency [33]. Now,
facilitated by the CRISPR-Cas system, innovative strate-
gies have been developed that accelerate the generation
and expression of mutated variants. However, further
optimization of the screening method for desired mutants
would be required via growth-coupled or sensor-guided
strategies.
Diversifying the substrate scope of natural
hosts
There is growing interest in producing chemicals from
waste or inexpensive substrates to reach economic viabil-
ity and avoid competition with foodstuffs (Figure 3d). For
example, facilitated by CRISPR, a one-step integration
and optimization of the xylose utilization pathway has
been reported in E. coli, which gave a threefold increase in
the xylose utilization rate [34]. Similarly, a xylose/glucose
co-fermenting yeast was also developed by rational engi-
neering using markerless CRISPR tools and evolutionary
engineering, as well as overexpression of selected genes
from the pentose phosphate pathway [35]. As there is no
marker left, the co-fermenting yeast would be an excel-
lent platform strain to produce various chemicals. In
parallel, the previously mentioned BETTER method
was successfully used to reprogram xylose and glycerol
utilization to replace tailored RBSs in the original genes
[7]. The combinatorial re-programmed strains showed a
much higher growth rate on these two substrates, and at
the same time optimal RBSs were screened for efficient
gene expression based on the change of growth rate. The
use of current renewable substrates offers economical and
sustainable production of chemicals. Furthermore, the
emerging 3G biorefinery that uses CO2 as the carbon
source represents an attractive alternative for microbial
chemical production in a carbon-neutral manner [36].
In addition, it has been known that the adoption of
approximate substrates may give a higher theoretical
yield (Figure 3d). Recent advances in computational
biology and in silico modeling have facilitated the design
of efficient pathways for the desired chemical. Guided by
this, a synergetic biosynthetic pathway was designed and
constructed by the CRISPR system to enable simulta-
neous utilization of acetate and glucose, which increased
the carbon molar yield from 0.67 to 0.75 mol/mol for
glycolate production [37]. With a followed systematic
engineering, the final strain can produce 73.3 g/L glyco-
late in fed-batch fermentation, reaching a carbon yield ofwww.sciencedirect.com 0.6 mol/mol. In another work, facilitated by the CRISPR
system, E. coli was engineered to grow on ethanol for
producing acetyl-CoA derived compounds [38]. The
engineered strain was shown to produce 1.1 g/L of poly-
hydroxybutyrate or 24 mg/L of prenol from ethanol.
Compared with glucose or other substrates, this study
showed that ethanol provided building blocks for the
synthesis of acetyl-CoA derived compounds in a shorter
and more carbon-efficient pathway. As shown above, the
balance use of selected substrates will make cells to
efficiently utilize the feedstock and maximize the pro-
duction yield and rate of end products. This strategy has
been used to further improve the theoretical maximum
yield of a wide range of products by redesigning cell
metabolism to assimilate alternative feedstocks such as
fatty acids, glycerol, methanol, and formaldehyde [39].
Improvement of metabolic robustness
Following efficient chemical production, the accumu-
lated chemical products can sometimes be toxic to the
cells. Consequently, it is necessary to improve metabolic
robustness or tolerance of the host cell for maximized
productivity (Figure 3e). In a recent study, a combinato-
rial library targeting 25 genes was constructed based on
CRISPR and massively parallel oligomer synthesis for
improving ethanol resistance [40]. Several identified
mutants screened from the library not only increased
ethanol tolerance but also gave a twofold higher ethanol
production. Later, the same group was extended using
this method to improve the tolerance of styrene [41].
Similarly, the identified new mutations improved toler-
ance and the production of styrene at the same time. In
another report, it was found that stress tolerance mutants
could be screened by CRISPRi in the presence of 0.1 M
L-lactate [42]. Of the screened targets, a single repression
of the bcp2 gene made a 49% improvement in growth rate.
In the process of industrial fermentation, environmental
perturbations can affect the performance of a cell factory,
such as inhomogeneities caused by insufficient mixing.
Therefore, it is highly desirable to develop cells with
increased robustness in harsh conditions. Recently, a
Cas9-based approach was used to generate a genome-
wide library containing sequence deletions, substitutions,
and replacements [43]. Yeast mutants were screened with
improved resistance to various environmental perturba-
tions, including higher temperature, in the presence of
hydroxyurea or fluconazole. Finally, 68 small open read-
ing frames were found to be vital for the cell’s robustness.
A focused CRISPRa library was created to screen func-
tional genes for thermotolerance [44], and upregulation of
OLE1 was identified as a key factor in obtaining thermo-
tolerant yeast.
Feedstocks for actual fermentation utilize complex sub-
strates, which may include growth inhibitors, such as
furfural and acetic acid from lignocellulosic hydrolysate.Current Opinion in Biotechnology 2022, 73:34–42
40 Energy biotechnologyThe robustness of these inhibitory compounds is highly
desirable to alleviate the inhibition of growth and metab-
olism. A recent method called CHAnGE was reported
that conducts CRISPR-Cas9 and homology-directed
repair-assisted (HDR) genome-scale engineering [45].
The method can generate a genome-scale yeast mutant
library at single-nucleotide precision, and was applied to
improve the tolerance to furfural and acetic acid by 42-
fold and 20-fold, respectively. Meanwhile, the same
group combined oligo pools and the tri-functional
CRISPR for transcriptional activation/interference, and
gene deletion in genome-wide, which was applied to
identify genetic determinants for furfural tolerance [8].
Notably, several targets were only reported in this study.
Furthermore, this method also identified synergistic
interactions between chosen targets for enhanced furfural
tolerance. In another study, with dCas9-based CRISPRi
and CRISPRa, the tolerance towards wheat straw hydro-
lysate was successfully improved by tuning the expres-
sion of a previous known key gene, SSK2 [46]. The strain
with modified expression of SSK2 gave a 2.3-fold increase
in final biomass yield when grown in wheat straw
hydrolysate.
Perspectives and conclusions
The CRISPR-Cas system is becoming an essential tool to
accelerate the creation of cell factories for chemical
production. In particular, with the features of orthogonal-
ity and simplicity, CRISPR-Cas can easily be implemen-
ted in both model and non-model organisms. Further-
more, the capabilities of the CRISPR-Cas system have
been extended with the incorporation of novel functional
proteins [4], such as DNA polymerases, reverse transcrip-
tase, deaminases acting on RNA, or transposase. How-
ever, challenges still exist for some applications of the
CRISPR-Cas system.
The design and effectiveness of gRNA are sensitive to
many factors. There are now several software applica-
tions, websites, and rules that can predict the targeting
ability of gRNA [47]. However, their accuracy still needs
improvement. In CRISPRa and CRISPRi, there is also a
strict position effect determined by the chosen gRNA.
Recently, two studies showed a good understanding of
the rules for designing effective positions of gRNA target
sites [48,49]. There is also a growing interest in giving
gRNA design more flexibility by searching protospacer
adjacent motif (PAM) free nucleases [50].
To obtain a high-performing strain, it has been usual to
conduct combinatorial and multiplex editing/regulation
for tens or even hundreds of metabolic engineering
targets. Now, up to 12 sgRNAs can be assembled and
expressed with a co-expression of Csy4 [51]. Therefore,
we should pay more attention to developing strategies for
the expression of a greater number of gRNAs in one step.Current Opinion in Biotechnology 2022, 73:34–42 At present, most examples carried in genome-scale or
multiplex engineering by CRISPR-Cas are limited to a
growth-associated phenotype. However, it is highly
demanding to evaluate a large library of strains efficiently.
The integration of chemical-responsive sensors or high-
throughput small-scale culture and detection techniques
could change screening for new traits [52].
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